Literature DB >> 14970615

Delivery and expression of heterologous genes in mammalian cells using self-replicating alphavirus vectors.

Gunilla B Karlsson1, Peter Liljeström.   

Abstract

The RNA genomes of alphaviruses have been exploited to create highly efficient vectors for transient expression of foreign genes in mammalian cells and for use as vehicles for genetic vaccines. For Semliki Forest virus (SFV), a representative alphavirus, three strategies for in vitro and in vivo gene-delivery have been developed. One method relies on the packaging of recombinant vectors into suicidal viral particles and infection of target cells, whereas the other two methods are based on direct transfection of target cells, either by using naked DNA encoding the SFV replicon placed downstream of an RNA polymerase II dependent promoter, or by using in vitro transcribed RNA encoding the SFV replicon. All three approaches result in the delivery of a selfreplicating SFV vector into target cells, with expression of foreign genes being driven from a highly efficient viral subgenomic promoter.

Entities:  

Mesh:

Year:  2004        PMID: 14970615     DOI: 10.1385/1-59259-650-9:543

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  Structural evidence of glycoprotein assembly in cellular membrane compartments prior to Alphavirus budding.

Authors:  Pan Soonsawad; Li Xing; Emerson Milla; Juan M Espinoza; Masaaki Kawano; Michael Marko; Chyongere Hsieh; Hiromitsu Furukawa; Masahiro Kawasaki; Wattana Weerachatyanukul; Ranjana Srivastava; Susan W Barnett; Indresh K Srivastava; R Holland Cheng
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

2.  Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen.

Authors:  John B Schell; Nina F Rose; Kapil Bahl; Kathryn Diller; Linda Buonocore; Meredith Hunter; Preston A Marx; Ratish Gambhira; Haili Tang; David C Montefiori; Welkin E Johnson; John K Rose
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

3.  In vitro evolution of high-titer, virus-like vesicles containing a single structural protein.

Authors:  Nina F Rose; Linda Buonocore; John B Schell; Anasuya Chattopadhyay; Kapil Bahl; Xinran Liu; John K Rose
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

4.  Differential Phosphatidylinositol-3-Kinase-Akt-mTOR Activation by Semliki Forest and Chikungunya Viruses Is Dependent on nsP3 and Connected to Replication Complex Internalization.

Authors:  Bastian Thaa; Roberta Biasiotto; Kai Eng; Maarit Neuvonen; Benjamin Götte; Lara Rheinemann; Margit Mutso; Age Utt; Finny Varghese; Giuseppe Balistreri; Andres Merits; Tero Ahola; Gerald M McInerney
Journal:  J Virol       Date:  2015-09-02       Impact factor: 5.103

5.  Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding human immunodeficiency virus type 1 clade C immunogens.

Authors:  Petra Mooij; Sunita S Balla-Jhagjhoorsingh; Niels Beenhakker; Patricia van Haaften; Ilona Baak; Ivonne G Nieuwenhuis; Shirin Heidari; Hans Wolf; Marie-Joelle Frachette; Kurt Bieler; Neil Sheppard; Alexandre Harari; Pierre-Alexandre Bart; Peter Liljeström; Ralf Wagner; Giuseppe Pantaleo; Jonathan L Heeney
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

6.  Hybrid alphavirus-rhabdovirus propagating replicon particles are versatile and potent vaccine vectors.

Authors:  Nina F Rose; Jean Publicover; Anasuya Chattopadhyay; John K Rose
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-07       Impact factor: 11.205

7.  Intradermal electroporation of naked replicon RNA elicits strong immune responses.

Authors:  Daniel X Johansson; Karl Ljungberg; Maria Kakoulidou; Peter Liljeström
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

8.  Induction of Protective Immunity against Toxoplasma gondii in Mice by Nucleoside Triphosphate Hydrolase-II (NTPase-II) Self-amplifying RNA Vaccine Encapsulated in Lipid Nanoparticle (LNP).

Authors:  Fangjun Luo; Lina Zheng; Yue Hu; Shuxian Liu; Yan Wang; Zhongkui Xiong; Xin Hu; Feng Tan
Journal:  Front Microbiol       Date:  2017-04-05       Impact factor: 5.640

9.  Virus-Like Vesicles Based on Semliki Forest Virus-Containing Rabies Virus Glycoprotein Make a Safe and Efficacious Rabies Vaccine Candidate in a Mouse Model.

Authors:  Chengguang Zhang; Yuling Tian; Chen Chen; Zongmei Wang; Jie Pei; Chuhan Lin; Ming Zhou; Zhen F Fu; Ling Zhao
Journal:  J Virol       Date:  2021-08-04       Impact factor: 5.103

10.  Control of the rescue and replication of Semliki Forest virus recombinants by the insertion of miRNA target sequences.

Authors:  Kaspar Ratnik; Liane Viru; Andres Merits
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.